WebSeth Ettenberg, PhD, is the current President and CEO of BlueRock Therapeutics. Seth served as Chief Scientific Officer at BlueRock from 2024 – 2024. Prior to joining BlueRock, Seth was a founding member of the Unum Therapeutics team, where he served as Chief Scientific Officer. Web3 Mar 2024 · Prior to joining BlueRock, Dr. Ettenberg was a founding member of the Unum Therapeutics team, where he served as Chief Scientific Officer. In this role, Dr. Ettenberg …
BlueRock Therapeutics Appoints Seth Ettenberg, Ph.D.
Web13 Feb 2024 · Seth Ettenberg UMRX stock SEC Form 4 insiders trading Seth has made over 6 trades of the Unum Therapeutics stock since 2024, according to the Form 4 filled with … Web3 Mar 2024 · CAMBRIDGE, Mass., March 03, 2024 (GLOBE NEWSWIRE) -- BlueRock Therapeutics, LP today announced the addition of Seth Ettenberg, Ph.D. to the company’s senior leadership team. In his role as Chief ... rifampin med card
Seth Ettenberg - Strategic Advisor at Manifold Bio The Org
WebSeth Ettenberg is a Strategic Advisor at Manifold Bio, and they have also served as the Chief Scientific Officer at Unum Therapeutics, Oncology Biotherapeutics Head at the Cambridge site of Novartis, and Lab Head and Project Leader at CuraGen Corp. Ettenberg has been working in the field of oncology biotherapeutics for over 20 years. WebCAMBRIDGE, Mass., July 26, 2024 — BlueRock Therapeutics, a clinical stage biopharmaceutical company and wholly-owned subsidiary of Bayer AG, announced today that Emile Nuwaysir, Ph.D., current President and CEO, will transition to the position of BlueRock Board Chair, effective August 1, 2024. Current Chief Scientific Officer Seth … Web3 Mar 2024 · CAMBRIDGE, Mass., March 03, 2024 (GLOBE NEWSWIRE) -- BlueRock Therapeutics, LP today announced the addition of Seth Ettenberg, Ph.D. to the company’s senior leadership team. In his role as Chief ... rifampin meaning